baber/WOPTO huggingface dataset:
Patent AU-2018206846-B2 (AU)
Title: Industrial audio noise monitoring system
Inventor: SCHNAARE THEODORE
IPC: G01H3/12
Filed: 2018-07-20
Granted: 2020-08-13
Abstract: A wireless field device (100) for use in monitoring acoustic noise includes an acoustic sensor 
(102) configured to sense acoustic noise. Processing circuitry (114) coupled to the acoustic 
sensor (102) is configured to identify a hazardous noise condition based upon the sensed acoustic 
noise and a personnel noise exposure standard. Output circuitry (106) provides a warning output 
in response to an identified noise condition. A system (700) is also provided which uses one or 
more acoustic sensors implemented in wireless field mounted monitors.
6/10 
100 
102 106 
MIC FIELD 
SI5GNAL 
CONDITIONING 
104--, POWER 1110 
MICROCONTROLLER 
Fig. 6
Patent AU-2018207075-B2 (AU)
Title: Tension cutting casing and wellhead retrieval system
Inventor: PRAY JEFFERY SCOTT
IPC: E21B33/038
Filed: 2018-01-09
Granted: 2022-12-08
Abstract: An apparatus for use in a well includes a tubular mandrel (115) configured to connect to a downhole assembly. An outer hub is configured to attach to a wellhead (10) and has a bore therethrough. An inner housing (130) is disposed on the tubular mandrel (115) and configured to attach the outer hub (140) to the wellhead (10). A clutch assembly is disposed within the bore of the outer hub (140) and movable between a locked position and an unlocked position, wherein the tubular mandrel (115) is rotatable relative to the inner housing (130) to operate the downhole assembly in the unlocked position.
Patent AU-2018230521-B2 (AU)
Title: Pharmaceutical compositions and uses thereof
Inventor: STRAUB JULIE
IPC: A61K31/444
Filed: 2018-03-12
Granted: 2022-02-03
Abstract: Provided are pharmaceutical compositions useful for the treatment and/or prevention of a disorder, such as addiction. For example, pharmaceutical compositions are provided that comprise a first active pharmaceutical component (e.g., metyrapone) and a second active pharmaceutical component (e.g., oxazepam). The compositions may be constructed in such a manner as to limit the physical contact between the first and second active pharmaceutical components, thus preventing any degradation of the active pharmaceutical components resulting form interaction between the two components. The compositions may include at least one pharmaceutically acceptable excipient. Also provided are methods of making the compositions as well as kits containing materials to provide the compositions.
Patent AU-2018232958-B2 (AU)
Title: Scalable communication system
Inventor: NGUYEN RYAN
IPC: H04L12/58
Filed: 2018-09-19
Granted: 2019-12-12
Abstract: A centralized communication system (CCS) is disclosed that provides a modular, extendible, and scalable communication system that can exchange information between any information systems or networked devices. Information from a single source device or system can be selectively broadcast to one or more predetermined destination devices and systems rather than broadcast to every device on the network. Information may be filtered and processed at one or more selectable points in the communication flow between systems. In certain embodiments, an incoming message is received from the source device in the native message format using the native protocol of the source device and converted to an internal messaging format for internal handling within the CCS, then converted to the native message format of a receiving system and sent to the receiving system using its native protocol. In certain embodiments, a graphical representation of the topology of the CCS may be provided. a) bussow obsa wln sioldawalu (j ) jOMGLUj ieidepv -CNJ - - - - - - - J
Patent AU-2018288650-B2 (AU)
Title: Augmented reality user interface on mobile device for presentation of information related to industrial process, control and automation system, or other system
Inventor: LAYCOCK GRAEME
IPC: G06T19/00
Filed: 2018-06-14
Granted: 2021-07-01
Abstract: A method includes identifying (804) one or more first devices (406, 102a, 102b, 106) contained in at least one image (404, 414, 424, 434) captured by a mobile device (122, 200). The method also includes obtaining (806) data associated with at least one of: the one or more first devices and one or more second devices (406, 102a, 102b, 106) connected to or interacting with the one or more first devices. The method further includes presenting (808) information overlaid over the at least one image by the mobile device to a user, where the presented information includes the data or information based on the data. The presented information varies based on perceived distance or proximity of the mobile device to the one or more first devices.
Patent AU-2018331280-B2 (AU)
Title: Ursolic acid morpholine and diethanolamine salts
Inventor: TALLEY JOHN J
IPC: C07C279/26
Filed: 2018-09-06
Granted: 2023-05-25
Abstract: The invention provides diethanolamine and morpholine salts of ursolic acid. Compositions containing the salts, and methods of using the salts are also provided.
Patent AU-2018343159-B2 (AU)
Title: Aqueous oral care fluoride treatment compositions, and methods
Inventor: WANG YIZHONG
IPC: A61K33/16
Filed: 2018-09-04
Granted: 2021-10-28
Abstract: An aqueous oral care fluoride treatment composition, a method of providing fluoride to a patient's tooth surface, and a method of reducing the incidence of dental caries, wherein the composition includes: 0.1 wt-% to 3.0 wt-% of a crosslinked poly acid having carboxylic acid side groups; a pharmaceutically acceptable buffer; 1.0 wt-% to 2.5 wt-% of sodium fluoride; 0.025 wt-% to 1.75 wt-% of a multivalent cation salt; and at least 60 wt-% water; wherein the weight percentages are based on the total weight of the aqueous composition.
Patent AU-2018413231-B2 (AU)
Title: Refrigerator
Inventor: KEMMOTSU MASAKATSU
IPC: F25D17/08
Filed: 2018-03-13
Granted: 2021-10-21
Abstract: This refrigerator is provided with: a refrigeration chamber; a freezing chamber provided lower than the refrigeration chamber; and a storage chamber which is provided between the refrigeration chamber and the freezing chamber and is set to a higher temperature range than the freezing chamber. The refrigerator comprises a cooler which is disposed in an air path between a storage chamber rear wall on the rear surface side of the storage chamber and a main body rear wall constituting the rear surface of a main body part, and cools the air inside the main body part. The main body part is provided with: a refrigeration chamber return port through which the air in the refrigeration chamber passes when returning to the cooler; a storage chamber return port through which the air in the storage chamber passes when returning to the cooler; and a freezing chamber return port through which the air in the freezing chamber passes when returning to the cooler through an air path provided in the storage chamber rear wall. The refrigeration chamber return port and the storage chamber return port are each provided lower than the lower end of the cooler, and the freezing chamber return port is provided at a position between the lower end and the upper end of the cooler.
Patent AU-2019213348-B2 (AU)
Title: Bone Conduction Apparatus and Multi-Sensory Brain Integration Method
Inventor: REDFIELD RANDALL
IPC: H04R5/02
Filed: 2019-08-07
Granted: 2021-04-22
Abstract: The present disclosure provides a therapeutic method applicable to learning, attention, 
) cognitive and developmental disorders. This method combines auditory, visual and 
vestibular stimuli into a systematic method which can be customized to address individual 
learning, attention and processing disorders. This method may be wirelessly implemented in 
a group setting. A device for providing vestibular and somatosensory stimulation through 
bone conduction of sound waves to skeletal bones is provided in the form of a pad that is 
applied to or wrapped around the individual in treatment, which is comfortable in use and 
may contain particulate filler material capable of providing bone conduction stimulation 
adjacent to the location of a bone conduction transducer and expand the sound conduction 
site over a larger area.
Patent AU-2019225747-B2 (AU)
Title: Medication delivery device with a sensed element
Inventor: BYERLY ROY HOWARD
IPC: A61M5/315
Filed: 2019-02-20
Granted: 2022-05-26
Abstract: A medication delivery device including a device body and a dose setting component coupled to the device body. Component is rotatable relative to the device body in relation to an amount of a set or delivered dose. An annular sensed element, such as a metal or magnetic ring, is positioned on a proximal surface of the dose setting component. A carrier secures the sensed element to the dose setting component. The carrier includes a proximal overlapping support that is contactable against the sensed element opposite the proximal surface of the dose setting component. The carrier is configured to axially and rotationally fix the sensed element to the dose setting component. The device may include a dose detection system operable with the sensed element.
Patent AU-2019228842-B2 (AU)
Title: Ion conductor containing Li2B12H12 and LiBH4, method for producing same, and solid electrolyte for all-solid-state batteries, which contains said ion conductor
Inventor: NOGAMI GENKI
IPC: H01B13/00
Filed: 2019-02-22
Granted: 2023-10-19
Abstract: The present invention is able to provide a method for producing an ion conductor containing Li
Patent AU-2019240733-B2 (AU)
Title: Systems and methods for improved focus tracking using blocking structures
Inventor: CONDELLO DANILO
IPC: G02B6/122
Filed: 2019-10-07
Granted: 2021-07-08
Abstract: Systems and methods disclosed herein include an optical blocking structure that may 
include a frame defining an aperture, first and second elongate structural members each 
comprising first and second ends such that the first and second elongate structural members 
may be connected at their first ends to opposite sides of the aperture, and further such that the 
first and second elongate structural members may extend from the frame parallel to and in the 
same direction as one another; and an optically opaque blocking member positioned to extend 
between the respective second ends of the first and second blocking members.
Patent AU-2019378368-B2 (AU)
Title: Abnormality detection device and abnormality detection method
Inventor: NOZOE SUSUMU
IPC: G01M99/00
Filed: 2019-10-30
Granted: 2022-01-06
Abstract: Provided is an abnormality detection device with which, even if a plurality of target machines are being managed, early detection of an abnormality in each target machine is possible.　An abnormality detection device 10 which detects an abnormality in a target machine, wherein said abnormality detection device 10 comprises: a first acquisition unit 82 which acquires a drive side temperature of the target machine; a second acquisition unit 82 which acquires a non-drive side temperature of the target machine; a correlation storage unit 80 which stores a correlation between the drive side temperature and the non-drive side temperature which is based on the drive side temperature and the non-drive side temperature during normal operation of the target machine; a detection unit 85 which detects a deviation from the correlation stored in the correlation storage unit on the basis of the drive side temperature acquired by the first acquisition unit and the non-drive side temperature acquired by the second acquisition unit; and, an output unit 87 which outputs the deviation from the correlation which was detected by the detection unit as an abnormality in the target machine or as an abnormality indication.
Patent AU-2019426113-B2 (AU)
Title: JAK inhibitor and preparation method therefor
Inventor: LU TINGTING
IPC: C07D487/04
Filed: 2019-12-23
Granted: 2022-06-16
Abstract: The present invention provides a compound represented by general formula I or a pharmaceutically acceptable salt, stereoisomer, ester, prodrug, metabolite, solvate, or deuterated compound thereof. The compound is a JAK inhibitor and can prevent and/or treat an inflammatory disease or cancer in humans and/or animals.
Patent AU-2020200735-B2 (AU)
Title: Flavor composition and edible compositions containing same
Inventor: DIDZBALIS JOHN
IPC: A23L27/40
Filed: 2020-01-31
Granted: 2022-06-02
Abstract: FLAVOR COMPOSITION AND EDIBLE COMPOSITIONS CONTAINING SAME 
Abstract 
A flavor composition containing at least one, two, three, four, five or more peptide 
compound(s) that can be used to enhance the taste of edible compositions including sweet goods, 
such as confectionery goods, and savory goods, such as pet foods.
Patent AU-2020227061-B2 (AU)
Title: Polyurethane screen
Inventor: LIPA ANTHONY J
IPC: B07B1/46
Filed: 2020-09-03
Granted: 2022-04-21
Abstract: A molded polyurethane vibratory screen (10) including a body (12) having opposite side edge 
portions (14, 16), upper and lower edge portions (18, 20), an upper surface (22) and a lower 
surface (24), first members (101) extending between the side edge portions (14, 16) and 
second members (102) extending between the lower edge portion (18) and the upper edge 
portion (20), third members (203) substantially parallel and extending transversely between 
the side edge portions (14, 16) and having multiple first members (101) therebetween, fourth 
members (204) substantially parallel and extending transversely between the lower edge 
portion (18) and the upper edge portion (20) and having multiple second members (102) 
therebetween, reinforcement members (50) molded integrally with the third and fourth 
members (203, 204).
Patent AU-2020248612-B2 (AU)
Title: Pharmaceutical composition, comprising human hyaluronidase PH20 variant and drug, for subcutaneous injection
Inventor: PARK SOON JAE
IPC: A61K9/00
Filed: 2020-03-24
Granted: 2023-11-23
Abstract: The present invention relates to a pharmaceutical composition comprising (a) a drug and (b) a human PH20 variant. The human PH20 variant contained in the pharmaceutical composition according to the present invention includes an amino acid substitution at one or more positions selected from the alpha helix 8 sequence (S347-C381) and a linkage region (A333-R346) between alpha helix 7 and alpha helix 8 on the wild-type human pH20 having the amino acid sequence of SEQ IS NO: 1, and is optionally cleaved at an amino acid positioned at the N-terminal or C-terminal region. In addition, the pharmaceutical composition according to the present invention may further comprise a pharmaceutically acceptable additive, particularly, a stabilizer. Due to the advantage of the human PH20 variant, the pharmaceutical composition according to the present invention can exhibit a maximum therapeutic effect of the drug used together therewith.
Patent AU-2020261941-B2 (AU)
Title: Method for preparing stable peptide formulations
Inventor: BROWN GREGORY NELSON
IPC: A61K9/00
Filed: 2020-04-20
Granted: 2023-04-06
Abstract: The present invention provides an improved method for preparing a powder formulation containing a peptide. The present invention further provides an improved method for preparing a powder formulation containing glucagon or a glucagon analog, wherein said powder formulation is suitable for nasal administration.
Patent AU-2020279969-B2 (AU)
Title: High temperature sintering systems and methods
Inventor: HU LIANGBING
IPC: C04B35/00
Filed: 2020-05-18
Granted: 2023-11-30
Abstract: Disclosed are fast high-temperature sintering systems and methods. A method of fabrication includes positioning a material at a distance of 0-1 centimeters from a first conductive carbon element and at a distance of 0-1 centimeters from a second conductive carbon element, heating the first conductive carbon element and the second conductive carbon element by electrical current to a temperature between 500
Patent AU-2020334786-B2 (AU)
Title: Spinnable frames for spectacles
Inventor: MENDELSOHN ADAM
IPC: G02C5/20
Filed: 2020-07-20
Granted: 2023-04-20
Abstract: Spinnable frames for spectacles are provided. A spinnable frame allows a user to hold a distal end of one of the temples and freely spin the remainder of the spectacles around that end of the temple. A spin joint is provided in at least one of the temples that allows this spinning action. The spin joint may span an interface between the distal end of the temple and a proximal end of the temple, the proximal end being coupled to a front portion of the frame at a hinge interface. In this way, the temple arm is allowed to fold against the front portion for compact storage, as with conventional eyeglass frames, while facilitating spinning of the spectacles in a way that avoids excess forces on the hinge interface and/or other portions of the frame or lenses mounted therein.
Patent AU-2020364266-B2 (AU)
Title: Oral care compositions and methods of use
Inventor: ARORA PAYAL
IPC: A61K8/19
Filed: 2020-10-06
Granted: 2023-07-20
Abstract: This invention relates to oral care compositions comprising a cannabinoid, and one one more source(s) of zinc ions and/or stannous ions. The oral care composition may also comprise one or more stannous source(s). Methods of using and of making these compositions is also disclosed herein.
Patent AU-2020381082-B2 (AU)
Title: Protein purification
Inventor: POLILLI BRIAN
IPC: C07K14/005
Filed: 2020-11-06
Granted: 2022-09-22
Abstract: Described herein is a process for protein purification, particularly a process for the purification of a glycoprotein, such as an HIV envelope protein, useful for vaccines or biotherapeutics.
Patent AU-2020397271-B2 (AU)
Title: Chimeric antigen receptor T cell which can be efficiently prepared and safely used, preparation method therefor and use thereof
Inventor: LI JIANQIANG
IPC: C07K14/705
Filed: 2020-12-01
Granted: 2023-08-03
Abstract: Provided is a chimeric antigen receptor T cell which can be efficiently prepared and safely used, a preparation method therefor and the use thereof. The present invention also relates to a lentiviral recombinant vector which contains a CAR structure encoding sequence and a promoter MND which drives the expression of the CAR structure encoding sequence. The nucleotide sequence of the promoter MND is the positions 2838-3236 of sequence 1. In order to overcome the disadvantages of low transfection efficiency and a large number of cytokines being produced during current CAR-T treatment, a new chimeric antigen receptor is prepared by improving the initiation of the CAR structure by promoter, namely, using the MND promoter to initiate the CAR structure, and a T cell expressing the chimeric antigen receptor is prepared. The T cell has the property of having less of an impact on the expression of CAR molecules on the cell surface and has the advantage of alleviative cell killing effect when combined with a CD19 positive cell, which can greatly reduce the occurrence of cytokine storm and effectively improves safety.
Patent AU-2021202185-B2 (AU)
Title: Drug Dose Cartridge for an Inhaler Device
Inventor: DAVIDSON PERRY
IPC: A61M15/00
Filed: 2021-04-09
Granted: 2022-09-29
Abstract: Disclosed is a dose cartridge for an inhaler device which comprises a flat pallet of airflow
permeable material including a heat-vaporizing drug substance, the pallet having two opposing 
faces and being positioned in the dose cartridge so as to expose the two faces to airflow; a 
supporting member coupled to the pallet to support the pallet from at least one side of the pallet 
joining the two faces; and an electrically resistive heating element extending at least partially 
across at least one of the two opposing faces from an attachment with the supporting member. In 
some embodiments the resistive heating element is in thermal contact with and extends across at 
least two opposite surfaces of the pallet and comprises a U-shape with two ends around a hollow 
in which the pallet is positioned. In some embodiments a portion of the resistive heating element 
extending across the pallet comprises a barrier which prevents a granulate portion of the airflow
permeable material from leaving the inhaler dose cartridge; and the supporting member 
comprises a geometry shaped for attachment to a transport arm of a dose puller.
230K 230430 
230 
2309 2311 
2309 2303 
230 2306 
FIG. 5A 
230 2300 
2308 i 
2306 
230 
FIG. 5B
Patent AU-2021202816-B2 (AU)
Title: Espresso milk frother probe
Inventor: PURTON WILLIAM WESTMORE
IPC: A47J31/44
Filed: 2021-05-04
Granted: 2023-10-26
Abstract: ESPRESSO MILK FROTHER PROBE 
ABSTRACT 
A milk frothing apparatus which includes a steam probe which consists of an inner steam tube 
surrounded by an outer tube spaced annularly from the inner tube with a nozzle mounted on 
the end of said outer tube adjacent the outlet end of said inner tube. The air gap between the 
inner and outer tubes insulates the outer tube from the heat generated in the inner tube during 
the steam cycle. By using stainless steel the milk does not stick to the cool outer tube surface 
and no cleaning of the outer surface of the probe is necessary. The steam itself keeps the 
inner surfaces of the probe clean.
Patent AU-2021212112-B2 (AU)
Title: Audio response playback
Inventor: LANG JONATHAN P
IPC: H04R3/00
Filed: 2021-08-06
Granted: 2022-09-29
Abstract: Audio Response Playback 
Abstract 
A computing device, comprising: 
at least one processor; and 
a non-transitory computer-readable medium comprising program instructions that, when 
executed by the at least one processor, cause the first playback device to perform functions 
comprising: 
receiving via a network microphone device of a media playback system, a voice 
command detected by at least one microphone of the network microphone device, 
wherein the media playback system comprises a plurality of zones, and wherein the 
network microphone device is a member of a default playback zone; 
dynamically selecting an audio response zone from the plurality of zones to play 
an audio response to the voice input and foregoing selection of the default playback 
zone, wherein the selected zone comprises a playback device, and wherein the 
dynamically selecting comprises determining that the network microphone device is 
paired with the playback device; and 
causing the playback device of the selected zone to play the audio response.
Patent AU-2021269302-B2 (AU)
Title: System and method for coupled detection of syntax and semantics for natural language understanding and generation
Inventor: BURCHARD PAUL
IPC: G10L15/00
Filed: 2021-11-16
Granted: 2021-12-23
Abstract: OF THE DISCLOSURE 
A method includes performing (410, 506), with at least one processing device (102), at 
least one of natural language understanding and natural language generation using both (i) a 
semantic word and clause representation generated from syntactically-labeled context and (ii) 
a syntax generated from common semantic relations between sequential words and clauses.  
The method could include generating (404) the semantic word and clause representation and/or 
generating (406) the syntax. The semantic word and clause representation and the syntax could 
be generated iteratively (402-406).
Patent AU-2021298029-B2 (AU)
Title: Sweet protein from truffle
Inventor: NADAL MARINA
IPC: A23L2/60
Filed: 2021-06-25
Granted: 2023-08-24
Abstract: Newly identified fungal sweet-taste modifying proteins, and the cDNA encoding said proteins are described. Specifically, Myd proteins active in sweet taste activation, and the cDNA encoding the same, are described, along with methods for isolating such cDNA and for isolating and expressing such proteins. Also disclosed is use of a sweetening composition which includes the proteins of the invention, and methods to provide improved flavor to a product for oral administration.